YARAL Pharma

YARAL Pharma is a private, commercial-stage generics company founded in 2019 and headquartered in San Diego, California. As the U.S. arm of IBSA, it leverages its parent company's manufacturing expertise and pipeline to commercialize authorized generics in therapeutic areas like pain and endocrinology, with plans to expand into dermatology and reproductive medicine. The company's strategy centers on ensuring supply continuity, forming strategic partnerships, and providing smarter solutions within the generic drug market to enhance healthcare outcomes.

Leverages the formulation, manufacturing, and regulatory expertise of its parent company, IBSA, to develop and commercialize authorized generics and complex generic medicines.

YARAL competes against large, established generic drug manufacturers (e.g., Teva, Sandoz, Mylan) and other specialty generics companies. Its differentiation is based on the quality and supply reliability associated with its parent company's branded heritage, a focus on customer service, and targeting specific therapeutic niches with complex or authorized generics.